Atrophy Clinical Trial
Official title:
Effect of Whole Body Vibration on Bone and Fall Related Parameters - the Erlangen Longitudinal Vibration Study (ELVIS)
The effect of whole body vibration (WBV) on bone strength and fall frequency in older adults is still vague. Although there is some evidence that WBV may impact Bone Mineral Density in very frail elderly, there is a lack of data concerning the effect of WBV in community-living elderly woman. We hypothesize that WBV significantly affects bone parameters as assessed by DXA, QCT, US and bone markers with parallel positive changes of fall related risk factors (power, strength, balance, and reaction time). We further hypothesize that the effects of WBV were superior to conventional resistance exercise.
Status | Terminated |
Enrollment | 150 |
Est. completion date | July 2007 |
Est. primary completion date | |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 65 Years and older |
Eligibility |
Inclusion Criteria: - community living elderly females >/=65 years - live expectation > 2 years Exclusion Criteria: - secondary osteoporosis - CVD-events including stroke - participation in other studies - medication and illness affecting bone metabolism within the last 2 years - medication with impact on falls - low physical performance (<50 Watt during ergometry) - excessive alcohol-intake |
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind, Primary Purpose: Prevention
Country | Name | City | State |
---|---|---|---|
Germany | Institute of Medical Physics | Erlangen |
Lead Sponsor | Collaborator |
---|---|
University of Erlangen-Nürnberg Medical School | Institute of Biometrie and Medical Statistics, Netzwerk-Knochengesundheit, Siemens-Betriebskrankenkasse |
Germany,
Engelke K, Kemmler W, Lauber D, Beeskow C, Pintag R, Kalender WA. Exercise maintains bone density at spine and hip EFOPS: a 3-year longitudinal study in early postmenopausal women. Osteoporos Int. 2006 Jan;17(1):133-42. Epub 2005 Aug 12. — View Citation
Kemmler W, Engelke K, Baumann H, Beeskow C, von Stengel S, Weineck J, Kalender WA. Bone status in elite male runners. Eur J Appl Physiol. 2006 Jan;96(1):78-85. Epub 2005 Oct 26. — View Citation
Kemmler W, Weineck J, Kalender WA, Engelke K. The effect of habitual physical activity, non-athletic exercise, muscle strength, and VO2max on bone mineral density is rather low in early postmenopausal osteopenic women. J Musculoskelet Neuronal Interact. 2004 Sep;4(3):325-34. — View Citation
Stengel SV, Kemmler W, Pintag R, Beeskow C, Weineck J, Lauber D, Kalender WA, Engelke K. Power training is more effective than strength training for maintaining bone mineral density in postmenopausal women. J Appl Physiol (1985). 2005 Jul;99(1):181-8. Epub 2005 Mar 3. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | BMD after 6, 12 and 18 months | |||
Primary | strength | |||
Primary | power | |||
Secondary | balance | |||
Secondary | bone markers |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02781623 -
Quantifying Quadriceps Atrophy Following Tibial Plateau Fracture
|
||
Completed |
NCT02497547 -
An Efficacy Study of Vagitocin in Postmenopausal Women With Symptoms of Vaginal Atrophy
|
Phase 2 | |
Completed |
NCT02332343 -
Sparing of the Fovea in Geographic Atrophy Progression
|
N/A | |
Completed |
NCT00566982 -
A Clinical Study to Evaluate the Safety of Ospemifene
|
Phase 3 | |
Completed |
NCT01586364 -
Long-Term Safety of Ospemifene 60 mg Oral Daily Dose for the Treatment of Vulvar and Vaginal Atrophy (VVA) in Postmenopausal Women Without a Uterus
|
Phase 3 | |
Active, not recruiting |
NCT05698316 -
A Collaborative Resource of Heidelberg Multimodal Imaging of Intermediate and Early Atrophic AMD Cases to Study Prediction of Disease Progression
|
||
Recruiting |
NCT05869812 -
Influence of β-hydroxy β-methyl Butyrate (HMB)Supplementation on Post-operative Muscle Mass and Function in Female Athletes
|
Phase 2 | |
Completed |
NCT02747641 -
Prospective, Open-Label, Single-Center, Non-Comparative Study to Assess the Use of Pixel CO2 Laser System (FemiLift) in the Treatment of Vulvovaginal Atrophy (VVA) in Postmenopausal Female Subjects
|
N/A | |
Completed |
NCT02770365 -
Comparative Safety and Efficacy of Two Treatments in the Treatment of Vulvar and Vaginal Atrophy
|
Phase 3 | |
Recruiting |
NCT02137824 -
A Modified Sinus Floor Elevation Technique - a Pilot Study on 12 Patients
|
N/A | |
Completed |
NCT01585558 -
Long-Term Safety of 30 mg and 60 mg Oral Daily Dose of Ospemifene in the Treatment of Vulvar and Vaginal Atrophy (VVA) in Postmenopausal Women With Intact Uterus
|
Phase 3 | |
Completed |
NCT02868749 -
Histology and Ultrasound Pilot Study of HA Gels Adipose Tissue
|
N/A | |
Recruiting |
NCT01911312 -
Evaluation of Thermal-Aided Muscle Stimulation
|
N/A | |
Completed |
NCT00729469 -
Efficacy and Safety of Ospemifene in the Treatment of Moderate to Severe Vaginal Dryness and Vaginal Pain Associated With Sexual Activity
|
Phase 3 | |
Completed |
NCT01553773 -
Postmenopausal Facial Skin After Estradiol and Genistein Topical Treatment
|
Phase 2 | |
Recruiting |
NCT02745366 -
Buccal Fat Pad Derived Stem Cells With Cortical Tenting in Posterior Mandible Reconstruction
|
Phase 1 | |
Completed |
NCT00807508 -
Leucine Supplementation in Elderly Men
|
Phase 1/Phase 2 | |
Completed |
NCT00744094 -
Resistance Training in Elderly
|
Phase 1/Phase 2 | |
Terminated |
NCT00267839 -
Effect of Exercise on Risk-factors of Elderly Women
|
Phase 3 | |
Completed |
NCT00276094 -
A Clinical Study to Evaluate Ospemifene in the Treatment of Vulvar and Vaginal Atrophy in Postmenopausal Women
|
Phase 3 |